0001104659-15-065569.txt : 20150916 0001104659-15-065569.hdr.sgml : 20150916 20150916170239 ACCESSION NUMBER: 0001104659-15-065569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150915 FILED AS OF DATE: 20150916 DATE AS OF CHANGE: 20150916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Ravindra CENTRAL INDEX KEY: 0001586835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 151110762 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2015-09-15 0 0001280600 ACCELERON PHARMA INC XLRN 0001586835 Kumar Ravindra 128 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 VP & Chief Scientific Officer Common Stock 2015-09-15 4 M 0 11485 3.88 A 89685 D Common Stock 2015-09-15 4 S 0 33000 35 D 56685 D Option to Purchase Common Stock 3.88 2015-09-15 4 M 0 11485 0 D 2020-12-02 Common Stock 11485 13515 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant. /s/ John D. Quisel, as attorney-in-fact for Ravindra Kumar 2015-09-16